A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects
暂无分享,去创建一个
M. G. Hornick | L. Potempa | Ashley Stefanski | Ibraheem Rajab | Margaret E. Olson | Haya R. Albanna | Alesia Gjoni | Griffin D. Hall | Peter C. Hart | Margaret E Olson | Haya Albanna
[1] P. Tang,et al. C-Reactive Protein: The Most Familiar Stranger. , 2023, Journal of immunology.
[2] W. Qiu,et al. Relevance of lipoproteins, membranes, and extracellular vesicles in understanding C-reactive protein biochemical structure and biological activities , 2022, Frontiers in Cardiovascular Medicine.
[3] Yi Wu,et al. Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity , 2022, Cell Biochemistry and Biophysics.
[4] L. Potempa,et al. Secretory quality control constrains functional selection-associated protein structure innovation , 2022, Communications Biology.
[5] L. Azamfirei,et al. Monomeric C-Reactive Protein: Current Perspectives for Utilization and Inclusion as a Prognostic Indicator and Therapeutic Target , 2022, Frontiers in Immunology.
[6] Y. Takada,et al. Anti-Monomeric C-Reactive Protein Antibody Ameliorates Arthritis and Nephritis in Mice , 2021, The Journal of Immunology.
[7] M. Slevin,et al. Antibody Protection against Long-Term Memory Loss Induced by Monomeric C-Reactive Protein in a Mouse Model of Dementia , 2021, Biomedicines.
[8] P. Hart,et al. How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression , 2020, Frontiers in Immunology.
[9] S. Meri,et al. Regulation of the Complement System by Pentraxins , 2019, Front. Immunol..
[10] Yanmin Zhang,et al. Regulation of C-reactive protein conformation in inflammation , 2019, Inflammation Research.
[11] A. Agrawal,et al. Evolution of C-Reactive Protein , 2019, Front. Immunol..
[12] P. Boysen,et al. The effect of lipopolysaccharide (LPS) on inflammatory markers in blood and brain and on behavior in individually-housed pigs , 2018, Physiology & Behavior.
[13] M. Slevin,et al. The Effect of C-Reactive Protein Isoforms on Nitric Oxide Production by U937 Monocytes/Macrophages , 2018, Front. Immunol..
[14] H. Bannasch,et al. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury , 2018, Front. Immunol..
[15] J. Ashworth,et al. Role of C-Reactive Protein at Sites of Inflammation and Infection , 2018, Front. Immunol..
[16] Wei Li,et al. An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma , 2018, Front. Immunol..
[17] R. Szewczyk,et al. Oxidation of C-reactive protein by hypochlorous acid leads to the formation of potent platelet activator. , 2018, International journal of biological macromolecules.
[18] Ming-hui Zhao,et al. Autoantibodies against C-Reactive Protein Influence Complement Activation and Clinical Course in Lupus Nephritis. , 2017, Journal of the American Society of Nephrology : JASN.
[19] M. Entman,et al. The role of C-reactive protein in innate and acquired inflammation: new perspectives , 2016, Inflammation and cell signaling.
[20] M. Daha,et al. Monomeric C-reactive protein inhibits renal cell-directed complement activation mediated by properdin. , 2016, American journal of physiology. Renal physiology.
[21] M. Entman,et al. Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease , 2016, Journal of Cardiovascular Translational Research.
[22] J. Filep,et al. C-reactive protein and inflammation: conformational changes affect function , 2015, Biological chemistry.
[23] J. Filep,et al. Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification , 2015, Biophysics reports.
[24] H. Bannasch,et al. A conformational change of C-reactive protein in burn wounds unmasks its proinflammatory properties. , 2014, International immunology.
[25] R. Virmani,et al. Dissociation of Pentameric to Monomeric C-Reactive Protein Localizes and Aggravates Inflammation: In Vivo Proof of a Powerful Proinflammatory Mechanism and a New Anti-Inflammatory Strategy , 2014, Circulation.
[26] T. D. Du Clos. Pentraxins: Structure, Function, and Role in Inflammation , 2013, ISRN inflammation.
[27] K. Peter,et al. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. , 2012, Cardiovascular research.
[28] K. Peter,et al. Amyloid Plaques Dissociate Pentameric to Monomeric C‐Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease? , 2012, Brain pathology.
[29] Ming-hui Zhao,et al. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein. , 2012, Human immunology.
[30] A. Blom,et al. Monomeric C‐reactive protein modulates classic complement activation on necrotic cells , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] L. Badimón,et al. Modified C‐Reactive Protein Is Expressed by Stroke Neovessels and Is a Potent Activator of Angiogenesis In Vitro , 2010, Brain pathology.
[32] A. Murphy,et al. Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques , 2009, Circulation research.
[33] Y. Wu,et al. Monomeric C‐reactive protein activates endothelial cells via interaction with lipid raft microdomains , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] X. Durán,et al. Short‐term myocardial ischemia induces cardiac modified C‐reactive protein expression and proinflammatory gene (cyclo‐oxygenase‐2, monocyte chemoattractant protein‐1, and tissue factor) upregulation in peripheral blood mononuclear cells , 2009, Journal of thrombosis and haemostasis : JTH.
[35] Y. Devaux,et al. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor α, on human monocytes , 2008, Thrombosis and Haemostasis.
[36] U. Singh,et al. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. , 2007, Journal of molecular and cellular cardiology.
[37] W. Lu,et al. Cell membranes and liposomes dissociate C‐reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] M. Wolzt,et al. C‐reactive protein is expressed and secreted by peripheral blood mononuclear cells , 2006, Clinical and experimental immunology.
[39] L. Badimón,et al. Endogenous Expression of C-Reactive Protein Is Increased in Active (Ulcerated Noncomplicated) Human Carotid Artery Plaques , 2006, Stroke.
[40] Steven V. Ley,et al. Targeting C-reactive protein for the treatment of cardiovascular disease , 2006, Nature.
[41] J. Zhao,et al. Effect of Modified C-Reactive Protein on Complement Activation: A Possible Complement Regulatory Role of Modified or Monomeric C-Reactive Protein in Atherosclerotic Lesions , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[42] In-kyu Lee,et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. , 2005, Journal of the American Society of Nephrology : JASN.
[43] J. Filep,et al. Loss of pentameric symmetry of C‐reactive protein induces interleukin‐8 production through peroxynitrite signaling in human neutrophils , 2005, Circulation research.
[44] E. Yeh,et al. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. , 2005, Journal of the American College of Cardiology.
[45] S. Devaraj,et al. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. , 2005, The American journal of pathology.
[46] L. Potempa,et al. Native and modified C-reactive protein bind different receptors on human neutrophils. , 2005, The international journal of biochemistry & cell biology.
[47] J. Filep,et al. Opposing Effects of C-Reactive Protein Isoforms on Shear-Induced Neutrophil-Platelet Adhesion and Neutrophil Aggregation in Whole Blood , 2004, Circulation.
[48] Seung‐Jung Park,et al. C-Reactive Protein Promotes Monocyte Chemoattractant Protein-1–Mediated Chemotaxis Through Upregulating CC Chemokine Receptor 2 Expression in Human Monocytes , 2004, Circulation.
[49] J. Filep,et al. Conformational Rearrangement in C-Reactive Protein Is Required for Proinflammatory Actions on Human Endothelial Cells , 2004, Circulation.
[50] E. Yeh,et al. Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells , 2003, Circulation.
[51] P. Gerke,et al. The kidney as a second site of human C‐reactive protein formation in vivo , 2003, European journal of immunology.
[52] J. Witztum,et al. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] Sridevi Devaraj,et al. Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells , 2002, Circulation.
[54] Ren-Ke Li,et al. A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis , 2002, Circulation.
[55] J. Filep,et al. Loss of Pentameric Symmetry of C-Reactive Protein Is Associated with Promotion of Neutrophil-Endothelial Cell Adhesion1 , 2001, The Journal of Immunology.
[56] S. Sui,et al. Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins. , 2001, Biochemical and biophysical research communications.
[57] P. Mcgeer,et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. , 2001, The American journal of pathology.
[58] James T. Willerson,et al. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.
[59] D. Bharadwaj,et al. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. , 2000, The Journal of clinical investigation.
[60] C. Mold,et al. Regulation of complement activation by C-reactive protein. , 1999, Immunopharmacology.
[61] B. Haimovich,et al. Phospholipase A2 Enzymes Regulate αIIbβ3-mediated, but not FcγRII Receptor-mediated, pp125FAK Phosphorylation in Platelets , 1999, Thrombosis and Haemostasis.
[62] S. Wood,et al. The physiological structure of human C-reactive protein and its complex with phosphocholine. , 1999, Structure.
[63] B. Anderson,et al. Conversion of native oligomeric to a modified monomeric form of human C-reactive protein. , 1998, The international journal of biochemistry & cell biology.
[64] E. Yeh,et al. Inhibition of α4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice , 1998 .
[65] J. Filep,et al. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. , 1997, The Journal of clinical investigation.
[66] J. Wright,et al. Expression of C-reactive protein by alveolar macrophages. , 1996, Journal of immunology.
[67] J. Volanakis,et al. Three dimensional structure of human C-reactive protein , 1996, Nature Structural Biology.
[68] L. Marnell,et al. C-reactive protein binds to Fc gamma RI in transfected COS cells. , 1995, Journal of immunology.
[69] M. Pepys,et al. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. , 1994, The Journal of clinical investigation.
[70] G. Vercellotti,et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor , 1993 .
[71] J. Zeller,et al. C‐reactive protein selectively enhances the intracellular generation of reactive oxygen products by IgG‐stimulated monocytes and neutrophils , 1992, Journal of leukocyte biology.
[72] G. Lozanski,et al. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. , 1992, Cytokine.
[73] L. Baum,et al. Anti-C-reactive protein inhibits the calcium-dependent stage of natural killer cell activation. , 1991, Journal of Immunology.
[74] H. Gewurz,et al. Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes. , 1988, Cellular immunology.
[75] H. Gewurz,et al. Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity , 1988, Inflammation.
[76] K. Inoue,et al. Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species. , 1988, Journal of immunology.
[77] H. Gewurz,et al. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP. , 1988, Journal of immunology.
[78] N. Tatsumi,et al. Neutrophil chemiluminescence induced by platelet activating factor and suppressed by C-reactive protein. , 1988, Clinica chimica acta; international journal of clinical chemistry.
[79] M. Pontet,et al. Modulation of human neutrophil function by C-reactive protein. , 1987, European journal of biochemistry.
[80] K. Zahedi,et al. Macrophage tumoricidal activity induced by human C-reactive protein. , 1986, Cancer research.
[81] P. V. van Helden,et al. Functional effects of CRP binding to nuclei. , 1986, Immunology.
[82] R. Anderson,et al. CRP and neutrophils: functional effects and complex uptake. , 1986, Clinical and Experimental Immunology.
[83] A. Steinberg,et al. C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro , 1985, The Journal of experimental medicine.
[84] C. Vigo. Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization. , 1985, The Journal of biological chemistry.
[85] B. Fiedel. Platelet agonist synergism by the acute phase reactant C-reactive protein. , 1985, Blood.
[86] K. Edwards,et al. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis. , 1984, Journal of immunology.
[87] C. Mold,et al. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. , 1984, Journal of immunology.
[88] H. Gewurz,et al. C-reactive protein antigenicity on the surface of human lymphocytes. , 1983, Journal of Immunology.
[89] H. Gewurz,et al. Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. , 1983, Molecular immunology.
[90] J. Volanakis,et al. Binding of human C4 to C-reactive protein-pneumococcal C-polysaccharide complexes during activation of the classical complement pathway. , 1983, Molecular immunology.
[91] B. Muller,et al. Early time course of the acute phase protein response in man. , 1983, Journal of clinical pathology.
[92] H. Gewurz,et al. Possible role for C-reactive protein in the human natural killer cell response , 1983, The Journal of experimental medicine.
[93] K. Edwards,et al. Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6 , 1982, Infection and immunity.
[94] J. Volanakis,et al. C‐REACTIVE PROTEIN BINDING SPECIFICITIES: ARTIFICIAL AND NATURAL PHOSPHOLIPID BILAYERS * , 1982, Annals of the New York Academy of Sciences.
[95] K. Edwards,et al. C‐REACTIVE PROTEIN REACTIVITY WITH COMPLEMENT AND EFFECTS ON PHAGOCYTOSIS * , 1982, Annals of the New York Academy of Sciences.
[96] J. Volanakis. COMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES * , 1982, Annals of the New York Academy of Sciences.
[97] T. Lint,et al. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae. , 1982, Journal of immunology.
[98] R. M. Simpson,et al. Activation of platelets by modified C-reactive protein. , 1982, Immunology.
[99] C. Mold,et al. Brief Definitive Report C-reactive Protein Is Protective against Streptococcus Pneumoniae Infection in Mice* , 2022 .
[100] C. Mold,et al. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. , 1981, Journal of immunology.
[101] C. Mold,et al. Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding. , 1981, Journal of immunology.
[102] M. Fridkin,et al. Studies on the activity of phorbol myrystate acetate on the human polymorphonuclear leukocytes , 1979, Experientia.
[103] I. Kushner,et al. Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit , 1978, The Journal of experimental medicine.
[104] H. Gewurz,et al. Interactions of C-reactive protein with the complement system. II. C- reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations , 1975, The Journal of experimental medicine.
[105] H. Gewurz,et al. INTERACTIONS OF C-REACTIVE PROTEIN WITH THE COMPLEMENT SYSTEM , 1974, The Journal of experimental medicine.
[106] J. Volanakis,et al. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. , 1974, Journal of immunology.
[107] C. Kindmark. Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. , 1971, Clinical and experimental immunology.
[108] Mark B Pepys,et al. C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.
[109] P. Zipfel,et al. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells. , 2009, Molecular Immunology.
[110] E. Downs,et al. Modulation of human monocyte chemotaxis and procoagulant activity by human C-reactive protein (CRP). , 1986, Lymphokine research.
[111] R. Russell,et al. Leucocytes and chemotaxis. , 1977, Agents and actions. Supplements.
[112] G. Weissmann,et al. Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. , 1974, The Journal of clinical investigation.